RT Journal Article
SR Electronic
A1 Jacobson, Anne
T1 Positive Trends in FIRE Hint at Protection from Reperfusion Injury
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 6
SP 24
OP 25
DO 10.1177/155989770800800615
UL http://mdc.sagepub.com/content/8/6/24.abstract
AB FX06, a fibrin-derived peptide, may reduce myocardial necrosis that is associated with successfully reperfused acute ST-segment elevation myocardial infarction, according to results from the FX06 In Reperfusion [FIRE] trial. The FIRE trial showed only modest trends in favor of FX06 but suggests possible protection from reperfusion injury.